
Sign up to save your podcasts
Or


It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.
By Mark Ebell4.7
9292 ratings
It's cardiovascular day at Primary Care Update as Kate, Mark and Henry discuss bleeding risk with diltiazem in treatment for atrial fibrillation, whether alteplase improves outcomes in patients with minor ischemic stroke, and whether to continue beta-blockers long-term after acute MI with preserved ejection fraction.

135 Listeners

707 Listeners

504 Listeners

297 Listeners

303 Listeners

268 Listeners

3,381 Listeners

1,144 Listeners

196 Listeners

89 Listeners

520 Listeners

365 Listeners

253 Listeners

378 Listeners

325 Listeners